Literature DB >> 8547728

Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients.

M F Bonfiglio1, S M Traeger, K L Kier, B R Martin, D T Hulisz, S R Verbeck.   

Abstract

OBJECTIVE: To define the incidence and severity of thrombocytopenia in a mixed medical-surgical population of critically ill patients and to examine factors that may be related to the development of thrombocytopenia.
DESIGN: Retrospective chart review of 314 critically ill patients requiring at least 3 days of critical care.
SETTING: A 17-bed combined medical-surgical intensive care unit (ICU) in a 560-bed tertiary care community hospital. PATIENTS: Medical and surgical patients admitted to the ICU.
INTERVENTIONS: All medical records over the duration of the ICU stay were reviewed. All scheduled medications, including dosage and start/stop dates, were recorded. All platelet counts, placement of pulmonary artery catheters, liver function test results, and admission serum creatinine concentrations were collected. MEASUREMENT AND MAIN
RESULTS: Thrombocytopenia (platelet count less than 200 x 10(9)/L) was observed frequently, but rarely reached a severe stage (7 patients). No single diagnostic category was significantly associated with thrombocytopenia alone, although the combination of sepsis syndrome/septic shock and respiratory failure was strongly correlated (p < 0.0001) with thrombocytopenia. Liver function abnormalities were correlated strongly with thrombocytopenia, and the majority of patients (5 of 7) with severe thrombocytopenia (less than 20 x 10(9)/L) were found to have concurrent severe alterations in liver function test results. Pulmonary artery catheter placement and heparin exposure were associated strongly with thrombocytopenia (p < 0.0001). Drug therapies that were correlated with thrombocytopenia included heparin and vancomycin (p < 0.05). Hemodynamic instability was correlated strongly with the presence and severity of thrombocytopenia. In a stepwise linear regression model, the admission platelet count accounted for the largest proportion of the variance (43%), followed by hemodynamic instability (8%) and the requirement for inotropic agents (2%).
CONCLUSIONS: Thrombocytopenia in the critically ill occurs frequently, rarely reaches severely depressed concentrations, and primarily represents a manifestation of disease processes initiated prior to admission. Hemodynamic instability and/or heparin exposure appear to be the strongest identifiable correlates with thrombocytopenia. Although these may cause infrequent isolated cases, other specific drug causes of thrombocytopenia are not responsible for the majority of cases of thrombocytopenia in the critically ill.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547728     DOI: 10.1177/106002809502900901

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  11 in total

Review 1.  Drug-induced thrombocytopenia in the coronary care unit.

Authors:  N M Patnode; P J Gandhi
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

2.  Effects of Baseline Thrombocytopenia and Platelet Decrease Following Renal Replacement Therapy Initiation in Patients With Severe Acute Kidney Injury.

Authors:  Benjamin R Griffin; Anna Jovanovich; Zhiying You; Paul Palevsky; Sarah Faubel; Diana Jalal
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

Review 3.  Vancomycin-Induced Thrombocytopenia: A Narrative Review.

Authors:  Mehdi Mohammadi; Zahra Jahangard-Rafsanjani; Amir Sarayani; Molouk Hadjibabaei; Maryam Taghizadeh-Ghehi
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

4.  Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.

Authors:  Fabrice Thiolliere; Anne Françoise Serre-Sapin; Jean Reignier; Marcel Benedit; Jean Michel Constantin; Christine Lebert; Dominique Guélon; Jean François Timsit; Bertrand Souweine
Journal:  Intensive Care Med       Date:  2013-06-06       Impact factor: 17.440

Review 5.  Drug-induced thrombocytopenia.

Authors:  Gian Paolo Visentin; Chao Yan Liu
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

6.  Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study.

Authors:  Darryl Abrams; Matthew R Baldwin; Matthew Champion; Cara Agerstrand; Andrew Eisenberger; Matthew Bacchetta; Daniel Brodie
Journal:  Intensive Care Med       Date:  2016-03-23       Impact factor: 17.440

7.  The incidence, causes, and prognostic significance of new-onset thrombocytopenia in intensive care units: a prospective cohort study in a Korean hospital.

Authors:  So Yeon Lim; Eun Ju Jeon; Hee-Jin Kim; Kyeongman Jeon; Sang-Won Um; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Gee Young Suh
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

8.  Microangiopathic Hemolytic Anemia in 57-year-old Woman with Borderline Serous Tumor of the Ovary: Real-Time Management of Common Pathways of Hemostatic Failure.

Authors:  Gloria J Morris; Henry C Yaeger; Francis Hamm; Sibyl Irwin; Salvatore J Scialla
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-06       Impact factor: 2.576

9.  Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome.

Authors:  Chakradhar Venkata; Rahul Kashyap; J Christopher Farmer; Bekele Afessa
Journal:  J Intensive Care       Date:  2013-12-30

10.  Thrombocytopenia and platelet course on hospital mortality in neurological intensive care unit: a retrospective observational study from large database.

Authors:  Dawei Zhou; Zhimin Li; Lei Wu; Guangzhi Shi; Jianxin Zhou
Journal:  BMC Neurol       Date:  2020-05-30       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.